The MS Clinic at Duke was formed to facilitate excellent patient care, clinical and basic research, concerning immune diseases of the CNS. Research interests include drug trials, genetic localization, and rehabilitation. Faculty have participated in multiple treatment trials for MS using cyclosporine, beta-seron, avonex/rebif and steroids for optic neuritis.
Vani Chilukuri, M.D.
Barrie Hurwitz, M.D.
Carmelo Graffagnino, M.D.
E. W. Massey, M.D.
Joel Morgenlander, M.D.
For more information:
National Multiple Sclerosis Society
